Targeting Bromodomain and Extra-Terminal (BET) Family Proteins in Castration-Resistant Prostate Cancer (CRPC)
Jonathan Welti(Institute of Cancer Research), Johann S. de Bono(Royal Marsden NHS Foundation Trust), George Seed(Institute of Cancer Research), Wei Yuan(Shanghai Public Health Clinical Center), Gunther Boysen, Veronica Gil(Cancer Research UK), Antje Neeb(Institute of Cancer Research), Ram S. Mani(Southwestern Medical Center), David Dolling(Institute of Cancer Research), Matthew Clarke(Institute of Cancer Research), Mateus Crespo(Institute of Cancer Research), Eleanor Knight(Cancer Research UK), Wendy S. Halsey(GlaxoSmithKline (United States)), Ganesh V. Raj(The University of Texas Southwestern Medical Center), Jeffrey C. Francis(Institute of Cancer Research), Amanda Swain(Institute of Cancer Research), Adam Sharp(Institute of Cancer Research), Stephen R. Plymate(VA Puget Sound Health Care System), Daniel Nava Rodrigues(Institute of Cancer Research), Jian Ning(Cancer Research UK), Ashley M. Hughes(GlaxoSmithKline (United States)), Suzanne Carreira(Institute of Cancer Research), Alec Paschalis(Royal Marsden NHS Foundation Trust), Semini Sumanasuriya(Institute of Cancer Research), Ines Figueiredo(Institute of Cancer Research), Arul M. Chinnaiyan(University of Michigan)
Cited by 158
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
How To Build and Interpret a Nomogram for Cancer Prognosis
|Journal of Clinical Oncology|2008|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Abiraterone in Metastatic Prostate Cancer without Previous Chemotherapy
|New England Journal of Medicine|2012|2.8k